ZLAB Valuation

Zai Lab Ltd

Add to Watchlist

Advanced Chart

31.770

-4.920(-13.410%)

Overview
Forecast
Valuation

ZLAB Relative Valuation

ZLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZLAB is overvalued; if below, it's undervalued.

Historical Valuation

Zai Lab Ltd(ZLAB) is now in theOvervaluedzone, suggesting that its currentforward PSratio of7.10is consideredOvervaluedcompared with the five-year average of26.77.The fair price of Zai Lab Ltd(ZLAB)is between19.68to28.60according to relative valuation methord.Compared to the current price of31.77USD, Zai Lab Ltd isOvervalued By 11.07%.

Relative Value

Fair Zone

19.68-28.60

Current Price：31.77

11.07%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

4.07

P/B

Median3y

0.90

Median5y

0.84

-5.51

FCF Yield

Median3y

-11.41

Median5y

-9.13

Competitors Valuation Multiple

The average P/S ratio for ZLAB's competitors is 5.40, providing a benchmark for relative valuation. Zai Lab Ltd Corp (ZLAB) exhibits a P/S ratio of 7.10, which is 31.47% above the industry average. Given its robust revenue growth of 65.68%, this premium appearssustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap